1
Participants
Start Date
October 3, 2022
Primary Completion Date
December 27, 2022
Study Completion Date
December 27, 2022
Nivolumab
Specified dose on specified days
Ipilimumab
Specified dose on specified days
BMS-986207
Specified dose on specified days
Placebo
Specified dose on specified days
Local Institution - 0056, Wahroonga
Local Institution - 0062, Buenos Aires
Local Institution - 0021, Buenos Aires
Local Institution - 0011, Buenos Aires
Local Institution - 0009, Pergamino
Local Institution - 0063, Orange
Local Institution - 0034, Mechelen
Local Institution - 0041, Alicante
Local Institution - 0052, Warrnambool
Local Institution - 0057, San Juan
Local Institution - 0040, Charleroi
Local Institution - 0043, Mons
Local Institution - 0017, Gera
Local Institution - 0019, Sint-Niklaas
Local Institution - 0049, Brooklyn
Local Institution - 0020, Rozzano
Local Institution, Milan
Local Institution - 0039, Monza
Local Institution - 0046, Jaén
Local Institution - 0032, Madrid
Local Institution - 0033, Majadahonda
Local Institution - 0012, Charleston
Local Institution, Tallahassee
Local Institution - 0045, Pensacola
Local Institution - 0073, Gainesville
Local Institution - 0036, Orange City
Local Institution, West Palm Beach
Local Institution - 0044, Pessac
Local Institution - 0068, St. Petersburg
Local Institution - 0070, Fort Myers
Local Institution - 0076, Istanbul
Local Institution - 0066, Istanbul
Local Institution, Port Saint Lucie
Local Institution - 0001, Padua
Local Institution - 0065, Izmir
Local Institution - 0074, Edgewood
Local Institution - 0031, Saint-Priest-en-Jarez
Local Institution - 0030, Nantes
Local Institution - 0002, Ann Arbor
Local Institution - 0053, Milwaukee
Local Institution - 0067, Samsun
Local Institution - 0022, Frankfurt am Main
Local Institution - 0059, Wiesbaden
Local Institution - 0016, Rouen
Local Institution - 0028, Naples
Local Institution - 0023, München
Local Institution - 0005, Gauting
Local Institution - 0042, Toulon
Local Institution - 0077, Coeur d'Alene
Local Institution - 0081, Boise
Local Institution - 0080, Tucson
Local Institution - 0037, Limoges
Local Institution - 0078, Jerusalem
Local Institution - 0079, Jerusalem
Local Institution - 0013, Suresnes
Local Institution - 0051, Fountain Valley
Local Institution - 0035, Viña del Mar
Local Institution - 0015, Viña del Mar
Local Institution - 0064, Haifa
Local Institution - 0050, Santiago
Local Institution - 0061, Jerusalem
Local Institution - 0054, Rosario
Local Institution - 0048, Buenos Aires
Local Institution - 0024, Bydgoszcz
Local Institution - 0003, Lodz
Local Institution - 0038, Otwock
Local Institution - 0058, Szczecin
Local Institution - 0026, Barcelona
Local Institution - 0075, Barcelona
Local Institution - 0006, Barcelona
Local Institution - 0072, Yüreğir
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY